ARTICLE | Company News
ENMD sells thalidomide royalty stream
August 8, 2001 7:00 AM UTC
EntreMed (ENMD) sold its rights to future Thalomid thalidomide royalties to Royalty Pharma for $24.3 million. ENMD may receive an additional $3 million upon achievement of certain sales milestones, an...